• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD105在小鼠和人类内皮细胞中TGF-β1信号传导中的功能作用

Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells.

作者信息

Warrington Kelly, Hillarby M Chantal, Li Chenggang, Letarte Michelle, Kumar Shant

机构信息

Division of Laboratory and Regenerative Medicine, Medical School, The University of Manchester M13 9PT, UK.

出版信息

Anticancer Res. 2005 May-Jun;25(3B):1851-64.

PMID:16158917
Abstract

BACKGROUND

Angiogenesis is important in health and several disease states. CD105 is a proliferation-associated and hypoxia-inducible transmembrane protein abundantly expressed in angiogenic endothelial cells. CD105 is a receptor for transforming growth factors (TGF)-beta1 and -beta3. The exact mechanisms for CD105 regulation of vascular development have not been fully elucidated.

MATERIALS AND METHODS

In this study, an antisense approach to create a murine and a human stably transfected endothelial cell line expressing a reduction in CD105 protein was used.

RESULTS

We showed that inhibition of CD105 in cultured murine and human endothelial cells enhanced the ability of TGF-beta1 to suppress growth and migration, and influenced TGF-beta1 promoter activity. TGF-beta1 not only reduced the length of the capillary-like structures, but also caused mortality in CD105-deficient murine antisense cells compared to control cultures. To determine whether CD105 affected TGF-beta1-induced gene expression, a luciferase assay in transiently transfected cells with p3TP-Lux promoter constructs was performed. Both murine and human antisense transfectants showed a significant increase in p3TP-Lux promoter activity. Further studies on the functional importance of CD105 was undertaken in irradiated normoxic and hypoxic cells. The levels of pro- and anti-apoptotic markers were also evaluated. There was an increase in pro-apoptotic marker (p53), but a reduction in anti-apoptotic marker (Bcl-2) in CD105-deficient cells.

CONCLUSION

These results provide direct evidence that CD105 antagonises the inhibitory effects of TGF-beta1 on human and murine vascular endothelial cells and that normal cellular levels of CD105 are required for the formation of new blood vessels.

摘要

背景

血管生成在健康及多种疾病状态中都很重要。CD105是一种与增殖相关且受缺氧诱导的跨膜蛋白,在血管生成的内皮细胞中大量表达。CD105是转化生长因子(TGF)-β1和-β3的受体。CD105调节血管发育的确切机制尚未完全阐明。

材料与方法

在本研究中,采用反义方法构建了表达CD105蛋白水平降低的小鼠和人稳定转染内皮细胞系。

结果

我们发现,在培养的小鼠和人内皮细胞中抑制CD105可增强TGF-β1抑制生长和迁移的能力,并影响TGF-β1启动子活性。与对照培养物相比,TGF-β1不仅缩短了毛细血管样结构的长度,还导致CD105缺陷型小鼠反义细胞死亡。为了确定CD105是否影响TGF-β1诱导的基因表达,对用p3TP-Lux启动子构建体瞬时转染的细胞进行了荧光素酶测定。小鼠和人反义转染子均显示p3TP-Lux启动子活性显著增加。对受辐照的常氧和缺氧细胞中CD105的功能重要性进行了进一步研究。还评估了促凋亡和抗凋亡标志物的水平。在CD105缺陷细胞中,促凋亡标志物(p53)增加,但抗凋亡标志物(Bcl-2)减少。

结论

这些结果提供了直接证据,表明CD105拮抗TGF-β1对人和小鼠血管内皮细胞的抑制作用,且新血管形成需要正常细胞水平的CD105。

相似文献

1
Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells.CD105在小鼠和人类内皮细胞中TGF-β1信号传导中的功能作用
Anticancer Res. 2005 May-Jun;25(3B):1851-64.
2
CD105 inhibits transforming growth factor-beta-Smad3 signalling.CD105抑制转化生长因子-β-Smad3信号通路。
Anticancer Res. 2004 May-Jun;24(3a):1337-45.
3
CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells.CD105拮抗转化生长因子β1对人血管内皮细胞的抑制信号。
FASEB J. 2000 Jan;14(1):55-64. doi: 10.1096/fasebj.14.1.55.
4
TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1.肿瘤坏死因子α下调血管内皮细胞中CD105的表达:与转化生长因子β1的对比研究。
Anticancer Res. 2003 Mar-Apr;23(2B):1189-96.
5
CD105 prevents apoptosis in hypoxic endothelial cells.CD105可防止缺氧内皮细胞凋亡。
J Cell Sci. 2003 Jul 1;116(Pt 13):2677-85. doi: 10.1242/jcs.00470. Epub 2003 May 13.
6
CD105 is important for angiogenesis: evidence and potential applications.CD105对血管生成至关重要:证据及潜在应用
FASEB J. 2003 Jun;17(9):984-92. doi: 10.1096/fj.02-0634rev.
7
Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium.转化生长因子-β1和CD105促进肝癌来源内皮细胞的迁移。
Cancer Res. 2008 Oct 15;68(20):8626-34. doi: 10.1158/0008-5472.CAN-08-1218.
8
Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells.抗内皮糖蛋白(CD105)单克隆抗体与转化生长因子-β在抑制人内皮细胞生长中的协同作用。
Int J Cancer. 2004 Jan 10;108(2):251-7. doi: 10.1002/ijc.11551.
9
Endoglin expression regulates basal and TGF-beta1-induced extracellular matrix synthesis in cultured L6E9 myoblasts.内皮糖蛋白的表达调控培养的L6E9成肌细胞中基础的和转化生长因子-β1诱导的细胞外基质合成。
Cell Physiol Biochem. 2004;14(4-6):301-10. doi: 10.1159/000080340.
10
Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.内皮糖蛋白在动脉损伤后过度表达,是转化生长因子-β诱导的平滑肌细胞迁移抑制所必需的。
Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2546-52. doi: 10.1161/01.atv.20.12.2546.

引用本文的文献

1
VEGF-E Attenuates Injury After Ischemic Stroke by Promoting Reparative Revascularization.血管内皮生长因子E通过促进修复性血管再生减轻缺血性中风后的损伤。
Eur J Neurosci. 2025 Apr;61(8):e70114. doi: 10.1111/ejn.70114.
2
Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma.基于李斯特菌的免疫疗法靶向 CD105 可发挥抗血管生成和抗肿瘤功效,用于肾细胞癌。
Front Immunol. 2022 Nov 11;13:1038807. doi: 10.3389/fimmu.2022.1038807. eCollection 2022.
3
Endoglin in the Spotlight to Treat Cancer.
内皮糖蛋白成为癌症治疗新焦点。
Int J Mol Sci. 2021 Mar 20;22(6):3186. doi: 10.3390/ijms22063186.
4
Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes.使用基于肽的组合递送靶向VEGFA、VEGFR1和内皮糖蛋白基因的小干扰RNA的协同抗血管生成作用。
Pharmaceutics. 2019 Jun 6;11(6):261. doi: 10.3390/pharmaceutics11060261.
5
Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics.靶向血管生成因子的反义寡核苷酸作为潜在的癌症治疗药物
Mol Ther Nucleic Acids. 2019 Mar 1;14:142-157. doi: 10.1016/j.omtn.2018.11.007. Epub 2018 Nov 20.
6
Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy.内皮糖蛋白(CD105)在肝细胞癌进展和抗血管生成治疗中的作用。
Int J Mol Sci. 2018 Dec 5;19(12):3887. doi: 10.3390/ijms19123887.
7
Alterations in Hoffa's fat pad induced by an inflammatory response following idealized anterior cruciate ligament surgery.炎症反应导致理想化前交叉韧带手术后 Hoffa 脂肪垫的改变。
Inflamm Res. 2015 Aug;64(8):615-26. doi: 10.1007/s00011-015-0840-y. Epub 2015 Jun 20.
8
Biology of renal tumour cancer stem cells applied in medicine.应用于医学的肾肿瘤癌干细胞生物学
Contemp Oncol (Pozn). 2015;19(1A):A44-51. doi: 10.5114/wo.2014.47128.
9
Angiogenesis in myeloproliferative neoplasms, new markers and future directions.骨髓增殖性肿瘤中的血管生成、新标志物及未来方向。
Memo. 2014;7:206-210. doi: 10.1007/s12254-014-0142-z. Epub 2014 May 22.
10
CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells.CD105是一种用于将受体靶向基因转移到人类长期重建造血干细胞中的表面标志物。
Stem Cells Dev. 2015 Mar 15;24(6):714-23. doi: 10.1089/scd.2014.0455. Epub 2015 Jan 20.